I am a
Home I AM A Search Login

Papers of the Week


Papers: 23 Apr 2022 - 29 Apr 2022

PAIN TYPE:
Migraine/Headache


2022 Apr 26


Pain Ther

Lasmiditan for Patients with Migraine and Contraindications to Triptans: A Post Hoc Analysis.

Authors

Krege JH, Lipton RB, Baygani SK, Komori M, Ryan SM, Vincent M
Pain Ther. 2022 Apr 26.
PMID: 35471625.

Abstract

As 5-HT receptor agonists, triptans produce vasoconstriction and have cardiovascular contraindications and precautions. Lasmiditan, a selective 5-HT receptor agonist, has a low affinity for 5-HT receptors, does not cause vasoconstriction, and is free of cardiovascular contraindications and precautions. The objective of this post hoc analysis was to evaluate the efficacy and safety of lasmiditan in patients with and without at least one triptan contraindication.